Lotte Group turns to Merck KGaA’s US unit for leg up at new Syracuse biologics plant
Merck KGaA’s MilliporeSigma is extending a helping hand to Lotte Group as the South Korean conglomerate looks to make an impact on US soil.
MilliporeSigma, Merck KGaA’s life science business in the US and Canada, has signed a memorandum of understanding with the new Lotte biologics business, outlining a planned collaboration to help establish Lotte’s manufacturing capabilities in the US. MilliporeSigma will be a preferred supplier and provide Lotte with technical consulting, training and expertise, products, technologies and manufacturing solutions, according to MilliporeSigma.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.